Efficacious treatments for children exist but are not widely available. We are utilizing technology, design, behavioral theory and biomedical business innovation strategies to package and spread the Stanford Pediatric Weight Control Program to reach low-income children throughout the U.S. To accomplish this aim, we are guided by an approach that merges design thinking, behavioral science, and business development strategy.

Our long-term goal is to reduce health disparities by developing and applying omics technologies (genomics, transcriptomics, epigenomics, metabolomics, microbiomics) to more effectively prevent and treat excess weight gain and diabetes risk. The first step toward this goal, is to quantify metabolic and biomolecular differences that are associated with and/or predict obesity and diabetes risk, and to characterize the heterogeneous biological responses and moderators and mediators to interventions to reduce weight gain, among Latinx children participating in a randomized trial. The results of this study will enable discovery of new associations, predictions, and precision interventions not previously possible and will potentially inform future studies among Latinx and other minority populations.